NOV Inc. (NO8.F)

11.49

+0.39

+(3.56%)

As of 8:08:28 AM GMT+2. Market Open.

NOV Inc. Just Missed EPS By 23%: Here's What Analysts Think Will Happen Next

Shareholders might have noticed that NOV Inc. ( NYSE:NOV ) filed its quarterly result this time last week. The early...

Simply Wall St. 11 days ago

NOV
NOV Inc. price target lowered to $17 from $20 at JPMorgan

JPMorgan lowered the firm’s price target on NOV Inc. (NOV) to $17 from $20 and keeps an Overweight rating on the shares. Despite a Q1 beat that featured strong free cash flow conversion, NOV shares dropped, reflecting a softer Q2 outlook and full-year guidance reduction relative to consensus expectations, the analyst tells investors in a research note. The firm believes NOV continued to dispel some concerns around offshore trends in the deepwater. Published first on TheFly – the ultimate source

TipRanks 11 days ago

NOV
NOV First Quarter 2025 Earnings: EPS Misses Expectations

NOV ( NYSE:NOV ) First Quarter 2025 Results Key Financial Results Revenue: US$2.10b (down 2.4% from 1Q 2024). Net...

Simply Wall St. 13 days ago

NOV
NOV Reports First Quarter 2025 Results

HOUSTON, April 28, 2025--NOV Reports Q1 2025 Results

Business Wire 14 days ago

NOV
There's Been No Shortage Of Growth Recently For NOV's (NYSE:NOV) Returns On Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...

Simply Wall St. 18 days ago

NOV
Earnings Preview: Nov Inc. (NOV) Q1 Earnings Expected to Decline

Nov Inc. (NOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 21 days ago

NOV
NOV Announces Key Leadership Changes

HOUSTON, March 19, 2025--NOV Announces Key Leadership Changes

Business Wire last month

NOV
NOV Announces First Quarter 2025 Earnings Conference Call

HOUSTON, March 18, 2025--NOV Announces Q1 2025 Earnings Conference Call

Business Wire last month

NOV
NOV (NYSE:NOV) shareholders are still up 47% over 5 years despite pulling back 4.4% in the past week

It might be of some concern to shareholders to see the NOV Inc. ( NYSE:NOV ) share price down 11% in the last month...

Simply Wall St. last month

NOV
What Eli Lilly's $27B investment in US manufacturing means for GLP-1s

Mizuho healthcare equity strategist Jared Holz joins Julie Hyman and Josh Lipton on Market Domination to analyze the GLP-1 weight-loss drug market following Eli Lilly's (LLY) announcement of a substantial $27 billion investment in US manufacturing. Eli Lilly makes the weight-loss drugs Mounjaro and Zepbound. Holz highlights two significant implications of this investment: first, it could boost domestic production capacity for these increasingly popular medications; second, it might "circumvent or alleviate any tariff issues" related to these drugs, potentially creating supply chain advantages. Regarding consumer pricing, Holz says the "trajectory of these GLP-1s in terms of pricing is definitely down," noting Eli Lilly's ongoing efforts to improve patient affordability. Despite potential price reductions, Holz emphasizes the medications' extensive benefits beyond weight loss, including improved cardiovascular health, reduced stroke risk, and anti-inflammatory effects. Given this, he argues the drugs remain "very, very cheap" at current price points when you "look at what the drug can do in totality." Holz predicts a pill form of GLP-1s could come to market by 2027. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith

Yahoo Finance Video 2 months ago

LLY

NOV
NOV's (NYSE:NOV) Soft Earnings Are Actually Better Than They Appear

NOV Inc.'s ( NYSE:NOV ) stock was strong despite it releasing a soft earnings report last week. We think that investors...

Simply Wall St. 2 months ago

NOV
NOV Declares Regular Quarterly Dividend

HOUSTON, February 21, 2025--NOV Declares Regular Quarterly Dividend

Business Wire 2 months ago

NOV
NOV Full Year 2024 Earnings: EPS Beats Expectations

NOV ( NYSE:NOV ) Full Year 2024 Results Key Financial Results Revenue: US$8.87b (up 3.3% from FY 2023). Net income...

Simply Wall St. 2 months ago

NOV
The NOV Inc. (NYSE:NOV) Annual Results Are Out And Analysts Have Published New Forecasts

It's been a pretty great week for NOV Inc. ( NYSE:NOV ) shareholders, with its shares surging 14% to US$16.43 in the...

Simply Wall St. 3 months ago

NOV
NOV Inc (NOV) Q4 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...

NOV Inc (NOV) reports robust revenue and net income growth for 2024, while navigating industry headwinds and planning strategic shareholder returns.

GuruFocus.com 3 months ago

NOV
Why Nov Inc. (NOV) Went Up on Wednesday

We recently compiled a list of the 10 Companies Jump on Better Earnings, Outlook. In this article, we are going to take a look at where Nov Inc. (NYSE:NOV) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors seemed to have already priced in the news of […]

Insider Monkey 3 months ago

NOV

^GSPC
NOV Reports Fourth Quarter and Full-Year 2024 Earnings

HOUSTON, February 04, 2025--NOV Reports Q4 and Full Year 2024 Earnings

Business Wire 3 months ago

NOV
Analysts Estimate Nov Inc. (NOV) to Report a Decline in Earnings: What to Look Out for

Nov Inc. (NOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 3 months ago

NOV
Solaris Energy Infrastructure, Inc. (SEI) Soars 9.8%: Is Further Upside Left in the Stock?

Solaris Energy Infrastructure, Inc. (SEI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks 3 months ago

SEI

NOV
Is NOV Inc. (NOV) Among the Most Undervalued Stocks to Invest in for Under $20?

We recently published a list of 12 Most Undervalued Stocks to Invest in for Under $20. In this article, we are going to take a look at where NOV Inc. (NYSE:NOV) stands against other most undervalued stocks to invest in for under $20. As we know, nearly all sectors in the S&P 500 index saw […]

Insider Monkey 3 months ago

^GSPC

NOV

Performance Overview

Return	NO8.F	S&P 500 (^GSPC)
YTD	-16.07%	-0.64%
1-Year	-32.25%	+11.93%
3-Year	-27.70%	+45.24%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Breaking

NOV Inc. (NO8.F)

NOV Inc. Just Missed EPS By 23%: Here's What Analysts Think Will Happen Next

NOV Inc. price target lowered to $17 from $20 at JPMorgan

NOV First Quarter 2025 Earnings: EPS Misses Expectations

NOV Reports First Quarter 2025 Results

There's Been No Shortage Of Growth Recently For NOV's (NYSE:NOV) Returns On Capital

Earnings Preview: Nov Inc. (NOV) Q1 Earnings Expected to Decline

NOV Announces Key Leadership Changes

NOV Announces First Quarter 2025 Earnings Conference Call

NOV (NYSE:NOV) shareholders are still up 47% over 5 years despite pulling back 4.4% in the past week

What Eli Lilly's $27B investment in US manufacturing means for GLP-1s

NOV's (NYSE:NOV) Soft Earnings Are Actually Better Than They Appear

NOV Declares Regular Quarterly Dividend

NOV Full Year 2024 Earnings: EPS Beats Expectations

The NOV Inc. (NYSE:NOV) Annual Results Are Out And Analysts Have Published New Forecasts

NOV Inc (NOV) Q4 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...

Why Nov Inc. (NOV) Went Up on Wednesday

NOV Reports Fourth Quarter and Full-Year 2024 Earnings

Analysts Estimate Nov Inc. (NOV) to Report a Decline in Earnings: What to Look Out for

Solaris Energy Infrastructure, Inc. (SEI) Soars 9.8%: Is Further Upside Left in the Stock?

Is NOV Inc. (NOV) Among the Most Undervalued Stocks to Invest in for Under $20?

Performance Overview